Study reveals APOE-ε4 allele increases the risk for Alzheimer’s and cardiovascular disease

Previous research has revealed that the Apolipoprotein-ε4 (APOE-ε4) allele increases the risk for a variety of diseases in aging populations, specifically Alzheimer’s and cardiovascular disease. And yet, despite the negative effects of this genetic variant, it remains prevalent in approximately 20% of the human population.

MarketingRx roundup: Pfizer, Astellas’ Super Bowl spots; Lilly debuts new Alzheimer’s ad

Pfizer hits the mark with Queen and science: Pfizer announced a last-minute jump into the Super Bowl lineup the day before it aired a celebratory

February 14, 2024

Brainoware: A breakthrough AI approach using brain organoids for advanced computation

Study in Nature Electronics introduces “Brainoware,” an innovative AI hardware approach using brain organoid neural networks for complex tasks like speech recognition and nonlinear dynamic

December 13, 2023

Gene editing has had a big week in the spotlight. Here’s what’s going on

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello, everyone. Damian here

November 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.